24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cancer genetics<br />

val (DFI) than patients with other IL-10 -1082, -3575 and TNF-α -308<br />

genotypes. Also, patients with TNF-α -308GA+AA had better overall<br />

survival (OS) (Logrank test, p=0.0371) than patients with TNF-α -<br />

308GG.<br />

Conclusion. Homo- and/or heterozygous carriers <strong>of</strong> high IL-10 and<br />

TNF-α producer alleles were more susceptible to DLBCL (IL-10 -<br />

819CC, TNF-α -308GA+AA), but they had better DFI (IL-10 -1082GG,<br />

IL-10 -3575TT, TNF-α -308GA+AA) and OS (TNF-α -308GA+AA).<br />

TGF-β c10TT carriers (low-producer genotype) had better prognosis<br />

according IPI.<br />

P06.173<br />

Regulation <strong>of</strong> the leukemia associated oncogene and<br />

developmental regulator EVi1 by all-trans retinoic acid (AtRA)<br />

S. Bingemann, R. Wieser;<br />

Department for <strong>Human</strong> <strong>Genetics</strong>, <strong>Vienna</strong>, Austria.<br />

The EVI1 gene codes for a zinc finger protein with important roles<br />

in embryonic development and in myeloid leukemogenesis. It is transcribed<br />

into several mRNA species with variable 5’-ends. One <strong>of</strong> these<br />

mRNA variants, MDS1/EVI1, gives rise to an EVI1 protein with an extended<br />

N-terminus and with functions partially different from those <strong>of</strong><br />

the shorter EVI1 protein type. The other EVI1 5’-end variants are most<br />

likely translated into the same protein, i.e. the short EVI1 protein variant,<br />

but their variable 5’-UTRs can be expected to affect the regulation<br />

<strong>of</strong> protein expression. So far all-trans retinoic acid (ATRA) is the only<br />

known physiological regulator <strong>of</strong> EVI1 in mammalian cells.<br />

Using the teratocarcinoma cell line NT-2, we have investigated the induction<br />

<strong>of</strong> EVI1 by ATRA. Time course analyses showed that ATRA<br />

rapidly induces the EVI1 mRNA in NT-2 cells. A maximum is reached<br />

after approximately 48 hrs, except for the MDS1/EVI1 mRNA, which<br />

was noticeably induced only after 48 hrs. This response was already<br />

detectable with as little as 10 nM ATRA and affected all EVI1 mRNA<br />

variants, albeit to variable degrees. Using reporter gene assays, an<br />

ATRA responsive region <strong>of</strong> ~200 bp was identified within exon 1a <strong>of</strong><br />

EVI1. Chromatin immunoprecipitation (ChIP) experiments confirmed<br />

the binding <strong>of</strong> retinoic acid receptors RAR and RXR to a retinoic acid<br />

response element (RARE) in this region.<br />

We conclude that the EVI1 gene is a direct target <strong>of</strong> retinoic acid signaling<br />

and that its regulation via this pathway is mediated through an<br />

intragenic RARE.<br />

P06.174<br />

Alterations <strong>of</strong> herg is<strong>of</strong>orm expressions in pediatric acute<br />

myeloid leukemia and solid tumors<br />

M. Erdem 1 , T. A. Tekiner 2 , A. Fejzullahu 2 , S. Anak 3 , U. Ozbek 4 , F. Atalar 5 ;<br />

1 Yeditepe University, Department <strong>of</strong> <strong>Genetics</strong> and Bioengineering, Istanbul,<br />

Turkey, 2 Istanbul Technical University, Molecular Biology and <strong>Genetics</strong> Department,<br />

Istanbul, Turkey, 3 Istanbul University, Istanbul School <strong>of</strong> Medicine,<br />

Department <strong>of</strong> Pediatric Hematology and Oncology, Istanbul, Turkey, 4 Istanbul<br />

University, Institute <strong>of</strong> Experimental Medical Research (DETAE), <strong>Genetics</strong> Department,<br />

Istanbul, Turkey, 5 Istanbul University, Istanbul Medical Faculty, Child<br />

Health Institute, Department <strong>of</strong> Pediatric Endocrinology, Istanbul, Turkey.<br />

Expression <strong>of</strong> K + channels encoded by human ether-a-go-go related<br />

gene(herg) is reported to be deregulated in cancer cells.We studied<br />

the expression levels <strong>of</strong> herg1 and herg1b by qRT-PCR in 35 pediatric<br />

acute myeloid leukemia(pAML) patients together with a group <strong>of</strong> human<br />

tumor samples(n=40) and their healthy counterparts.A common<br />

HERG polymorphism(K897T) was also analyzed in pAML patients.Our<br />

results suggest that herg1 expression is lower in pAML patients compared<br />

to the control group which is composed <strong>of</strong> CD33+ cells isolated<br />

from healthy bone marrows(2,5fold).Herg1b expression was found<br />

to be higher in pAML patients(20 fold,p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!